Lentinan inhibits melanoma development by regulating the AKT/Nur77/Bcl-2 signaling axis
Year: 2024
Type: article
Abstract: Overall, LNT inhibited tumor growth and promoted apoptosis by regulating the AKT/Nur77/Bcl-2 pathway in melanoma cells. Our findings highlight the potential of LNT for drug development and clinical treatment of melanoma.
Source: Journal of Cancer
DOI: 10.7150/jca.100863
Authors: Xuebin Lai, Yanling Chen, Rongjie Huang, Fukai Zhu, Lanqian Huang, Nan Chen, Guipeng Li, Wenze Hou, Yutian Pan, Gulimiran Alitongbieke
Institutions: Minnan Normal University, Fujian Medical University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,337
OpenAlex ID: W4405256096
